Table 3 Results of ATRX expression status stratified by tumor location
From: ATRX immunostaining predicts IDH and H3F3A status in gliomas
Tumor location | ATRX loss/retention (%) | ATRX loss/retention (n) |
|---|---|---|
Frontal lobe | 48/29 | 79/27 |
Parietal lobe | 7/9 | 12/44 |
Temporal lobe | 26/30 | 43/139 |
Occipital lobe | 2/4 | 4/20 |
Thalamus | 1/2 | 1/8 |
Intraventricular | 1/2 | 1/10 |
Brainstem and midbrain | 1/2 | 1/11 |
Cerebellum | 1/5 | 2/24 |
Spinal cord | 1/10 | 1/49 |
Multiple locations | 13/6 | 21/27 |